Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
19.64
-0.85 (-4.15%)
Dec 5, 2025, 4:00 PM EST - Market closed
Simulations Plus Revenue
In the fiscal year ending August 31, 2025, Simulations Plus had annual revenue of $79.18M with 13.09% growth. Simulations Plus had revenue of $17.46M in the quarter ending August 31, 2025, a decrease of -6.45%.
Revenue (ttm)
$79.18M
Revenue Growth
+13.09%
P/S Ratio
4.99
Revenue / Employee
$371,732
Employees
213
Market Cap
395.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 79.18M | 9.17M | 13.09% |
| Aug 31, 2024 | 70.01M | 10.44M | 17.52% |
| Aug 31, 2023 | 59.58M | 5.67M | 10.52% |
| Aug 31, 2022 | 53.91M | 7.44M | 16.01% |
| Aug 31, 2021 | 46.47M | 4.88M | 11.73% |
| Aug 31, 2020 | Pro | Pro | Pro |
| Aug 31, 2019 | Pro | Pro | Pro |
| Aug 31, 2018 | Pro | Pro | Pro |
| Aug 31, 2017 | Pro | Pro | Pro |
| Aug 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SLP News
- 1 day ago - Why Shares of Simulations Plus Soared This Week - The Motley Fool
- 3 days ago - Simulations Plus: Buying On Long-Term Silico Drug-Development - Seeking Alpha
- 3 days ago - Why Simulations Plus Stock Was Soaring Today - The Motley Fool
- 3 days ago - Simulations Plus Stock Climbs On Earnings Strength, Biotech Market Rebound - Benzinga
- 4 days ago - Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results - Business Wire
- 4 weeks ago - SIMULATIONS PLUS INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Simulations Plus Investors to Contact the Firm Regarding Their Rights - GlobeNewsWire
- 6 weeks ago - SLP INVESTORS: Simulations Plus, Inc. Hit with Securities Fraud Investigation after Stock Plummets 26% -- Investors Urged to Contact BFA Law - GlobeNewsWire